Stock COCH ENVOY MEDICAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Envoy Medical, Inc.

Equities

COCH

US29415V1098

End-of-day quote Nasdaq
Other stock markets
 06:00:00 2024-05-27 pm EDT 		5-day change 1st Jan Change
2.62 USD -5.07% Intraday chart for Envoy Medical, Inc. -5.07% +44.70%
May. 15 Earnings Flash (COCH) ENVOY MEDICAL Reports Q1 Revenue $59,000 MT
May. 15 Envoy Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Earnings Flash (COCH) ENVOY MEDICAL Reports Q1 Revenue $59,000
MT
Envoy Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Envoy Medical to Present at the Planet MicroCap Showcase: Vegas 2024
GL
ROSEN, A LONGSTANDING LAW FIRM, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH
PR
COCH LOSS ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH
PR
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH
PR
Lake Street Raises Price Target on Envoy Medical to $6 From $3, Maintains Buy Rating
MT
Envoy Medical to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024
GL
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH
PR
COCH ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH
PR
Envoy Medical to Participate in the 36th Annual ROTH Conference
GL
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH
PR
Envoy Medical Secures Up To $10 Million Term Debt Financing to Advance Upcoming Clinical Trial
GL
Envoy Medical, Inc. Secures Up to $10 Million Term Debt Financing to Advance Upcoming Clinical Trial
CI
COCH LOSS ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH
PR
Envoy Medical, Inc. announced that it expects to receive $10 million in funding
CI
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH
PR
Newly Introduced Bipartisan Bill Seeks to Clarify Fully Implanted Active Middle Ear Hearing Devices as Prosthetics, Not Hearing Aids, Making Them Eligible for Medicare Coverage
GL
Envoy Medical CEO Brent Lucas Interviewed by Leading Healthcare Podcast Medical Alley
GL
Envoy Medical, Inc. to Present at The Microcap Conference
NE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. COCH Stock
  4. News Envoy Medical, Inc.